MedTrace Logo

Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver Transplantation

NCT07335523 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-04-30

No results posted yet for this study

Summary

The goal of this clinical trial is to determine the prevalence of exocrine pancreatic insufficiency (EPI) in a population of pediatric and adult participants with Alagille Syndrome (ALGS) post liver transplant. During the study, participants will:

* Consume a high fat diet
* Keep a diary of their abdominal signs and symptoms, and stool frequency and consistency
* Collect stool for laboratory testing

Conditions

  • Exocrine Pancreatic Insuficiency

Interventions

DIAGNOSTIC_TEST

Fecal Fat

coefficient of fat absorption

Sponsors & Collaborators

  • Alagille Syndrome Alliance

    collaborator UNKNOWN

  • Digestive Care, Inc.

    lead INDUSTRY

Eligibility

Min Age
7 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2027-05-31
Completion
2028-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07335523 on ClinicalTrials.gov